Lite Strategy, Inc. (LITS) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US55279B3015
Price
1.17 USD
Market cap
35.58 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
-170.94 %
Return on assets (ROA)
-166.66 %
Lite Strategy, Inc. financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 0.00 USD | – |
| Operating income | -17.46 m USD | -66.58 m USD |
| EBIT | -16.97 m USD | -71.42 m USD |
| Net income | -15.95 m USD | -71.15 m USD |
| Diluted EPS – continuing operations | -2.39 USD | -2.06 USD |
Full history since 2009, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Lite Strategy, Inc.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
More stocks
- Metagenomi Therapeutics, Inc. (MGX)
- Xos, Inc. (XOS)
- Mono Next Public Company Limited (MONO.BK)
- ATLANTIC AMERICAN CORP (AAME)
- Tonix Pharmaceuticals Holding Corp. (TNXP)
- CervoMed Inc. (CRVO)
- Bio Essence Corp (BIOE)
- Scientist Home Future Health Ltd (SHFH)
- ConnectM Technology Solutions, Inc. (CNTM)
- OLD MARKET CAPITAL Corp (OMCC)
- HeartBeam, Inc. (BEAT)
- PIONEER POWER SOLUTIONS, INC. (PPSI)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.